Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Voyager Therapeutics, Inc. - Common Stock (NQ:VYGR)

2.220 +0.170 (+8.29%)
Delayed Quote Updated: 11:54 AM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Voyager Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
News headline image
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Is Apexigen (APGN) Stock Up 97% Today? ↗
Apexigen (APGN) stock is rocketing higher on Monday following new coverage of the company from an analyst and heavy trading. 
Via InvestorPlace
News headline image
Why Is Party City (PRTY) Stock Up 41% Today? ↗
Party City (PRTY) stock is in the news Monday as investors prepare for the celebration goods company to file for bankruptcy. 
Via InvestorPlace
News headline image
Voyager Therapeutics' TRACER Capsids Show Encouraging Action In Animal Models ↗
 
Via Benzinga
News headline image
Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal ↗
Voyager Therapeutics' lucrative arrangement with a fellow biotech business is putting VYGR stock traders in a buying mood today. 
Via InvestorPlace
News headline image
Neurocrine Biosciences, Voyager Therapeutics Collaborate For Neurological-Focused Gene Therapies ↗
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 8, 2022 ↗
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million. 
Via Benzinga
News headline image
Voyager Therapeutics's Earnings Outlook ↗
Voyager Therapeutics (NASDAQ:VYGR) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Voyager... 
Via Benzinga
News headline image
Pfizer In-Licenses Voyager Therapeutics' AAV Capsid For Rare Neurologic Disease Target ↗
 
Via Benzinga
News headline image
7 Top-Rated Biotech Stocks to Buy for Q4 ↗
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
News headline image
Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024 ↗
 
Via Benzinga
News headline image
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
95 Biggest Movers From Yesterday ↗
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
83 Biggest Movers From Yesterday ↗
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
57 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Voyager Therapeutics Earnings Perspective: Return On Capital Employed ↗
According to Benzinga Pro, during Q4, Voyager Therapeutics (NASDAQ:VYGR) earned $5.71 million, a 122.71% increase from the preceding quarter. Voyager Therapeutics also posted a... 
Via Benzinga
News headline image
88 Biggest Movers From Yesterday ↗
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock rose 86.8% to $1.14 during Tuesday's regular session. The current volume of 2.6 million shares is 326.2% of Kala... 
Via Benzinga
News headline image
60 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Enservco Corporation (NYSE: ENSV) surged 228% to $8.20 after jumping around 85% on Monday. Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 168% to $0.8850. Hycroft... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Stealth BioTherapeutics (NASDAQ:MITO) shares increased by 22.1% to $0.65 during Tuesday's pre-market session. The company's market cap stands at $37.4... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... 
Via Benzinga
News headline image
Recap: Voyager Therapeutics Q4 Earnings ↗
Voyager Therapeutics (NASDAQ:VYGR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
Voyager Therapeutics Shares Jump On Novartis Option Agreement For Gene Therapy Programs ↗
Novartis AG (NYSE: NVS) has entered a license option agreement with Voyager Therapeutics Inc (NASDAQ: VYGR) for three capsids to use in potential gene... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.